Americafirst Capital Management »

Eagle Pharmaceuticals shares owned by Americafirst Capital Management

Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by Americafirst Capital Management from 13F filings

Historical chart of Americafirst Capital Management investment in Eagle Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eagle Pharmaceuticals held by Americafirst Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eagle Pharmaceuticals by Americafirst Capital Management

Quarter filed Position value Share count Share price at filing
2017-09-30 $434k 7.3k 59.64

More positions owned by Americafirst Capital Management

SYSCO Corporation (SYY)
Vaneck Vectors Etf Tr fallen angel hg (ANGL)
United States Treasury Note/bond us government
Edison International (EIX)
Exelon Corporation (EXC)
Us Treasury Bond 5.500 08/15/2028
United States Treasury Note/bond 2.25% 2/15/2027
U.s. Treasury Note 2.000% bond
United Sates Treasury Bond 4.75% 2/15/2041
Thermo Fisher Scientific (TMO)
Biogen Idec (BIIB)
Xcel Energy (XEL)
International Game Technology (IGT)
Sempra Energy (SRE)
Procter & Gamble Company (PG)

View all positions for Americafirst Capital Management

Top funds holding Eagle Pharmaceuticals

Nantahala Capital Management
AIGH Capital Management
Citigroup
Vanguard Group
AQR Capital Management
BlackRock
Morgan Stanley
BlackRock
Renaissance Technologies
Two Sigma Advisers
Marshall Wace
J. Goldman & Co
Assenagon Asset Management
Two Sigma Investments
Jacobs Levy Equity Management

View all funds holding Eagle Pharmaceuticals